Charles River Laboratories International (CRL) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is CRL's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

Fifth Third Bancorp raised its holdings in Charles River Laboratories International, Inc. (NYSE: CRL) by 24.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exc…

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Jefferies Global Healthcare Conference.…

Alpha Teknova (NASDAQ: TKNO - Get Free Report) and Charles River Laboratories International (NYSE: CRL - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two compa…

Commonwealth Equity Services LLC grew its stake in Charles River Laboratories International, Inc. (NYSE: CRL) by 733.4% in a recent quarter, according to the company in its most recent filing with the Securities and Exch…

Investors interested in Medical Services stocks are likely familiar with GMR Solutions Inc. (GMRS) and Charles River Laboratories (CRL). But which of these two stocks offers value investors a better bang for their buck r…

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River has announced a series of strategic investments and operational enhancements across its global Microbial Solutions network.…

Brighton Jones LLC increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE: CRL) by 546.1% during a recent quarter, according to its most recent Form 13F filing with the Securities and Ex…

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.…

Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.…

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Acquire Frontage's Bioanalysis and DMPK Businesses.…

Charles River Laboratories International NYSE: CRL raised its 2026 revenue and earnings outlook after third-quarter organic revenue growth accelerated to 4.7%, supported by demand for safety assessment and manufacturing …

Boston Trust Walden Corp reduced its stake in Charles River Laboratories International, Inc. (NYSE: CRL) by 13.0% during a recent quarter, according to its most recent 13F filing with the Securities and Exchange Commissi…

Charles River Laboratories International, Inc. (CRL) Q3 2026 Earnings Call Transcript…

CRL beats Q3 earnings and revenue estimates as organic growth and margin expansion drive results, prompting the company to raise its 2026 outlook.…

Although the revenue and EPS for Charles River (CRL) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates a…

Charles River Laboratories (CRL) came out with quarterly earnings of $3.09 per share, beating the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.43 per share a year ago.…

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Third-Quarter 2026 Results.…

CRL's Q3'26 results face pressure from declining segment revenues, but improving biopharma demand and strength in Microbial Solutions could provide support.…

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

Charles River Laboratories advanced during the quarter following a strong earnings report and an increase to full-year guidance. We exited the NCLH position during the quarter and redeployed proceeds into Royal Caribbean…

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River announces that its VCG database and methodology, designed to reduce animal use, will be used in an upcoming GLP study for Ipsen.…

Charles River Laboratories International, Inc. (NYSE: CRL - Get Free Report) Director James Foster sold 24,042 shares of the company's stock in a transaction dated Thursday, October 22nd. The shares were sold at an avera…

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River announced a collaboration with the U.S. FDA and Labcorp to develop screening tools to quantify and rank the abuse potential of new drugs.…

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) and Magellan Stem Cells, a private Australian biotech and cell-therapy firm, announce their collaboration to s…

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call.…

WILMINGTON, Mass. & LONDON--(BUSINESS WIRE)---- $CRL #DrugDiscover--Charles River Laboratories International, Inc. (NYSE: CRL) and Autolomous today announced the launch of Apollo Orchestrate™, a new capability within Cha…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 17. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

